Todd Peterson, Ph.D.

Chief Technology Officer

Dr. Peterson has over 25 years experience in industrial research and development in the areas of molecular biology, nucleic acids and genomics product and technology development. His experience encompasses clinical diagnostics, life science research tools and pharmaceutical discovery technologies and market segments. Prior to joining Synthetic Genomics, Dr. Peterson led Genomics and Synthetic Biology R&D at Life Technologies, a global leader in life science research tools that was later acquired by Thermo Fisher Scientific. Prior to Life Technologies, Dr. Peterson held research and development positions with increasing responsibilities at Genicon Sciences, Trega Biosciences, Hybritech and Gen-Probe where he focused on product and technology research, development, and commercialization.

Dr. Peterson was a postdoctoral fellow at the Max Planck Institute in Cologne Germany and received his Ph.D. in Microbiology at the University of Southern California School of Medicine.